Brief: United Laboratories International Participates In Bidding For National Centralised Procurement Of Pharmaceuticals
23/04/2024 16:25
April 23 (Reuters) - United Laboratories International
Holdings Ltd 3933.HK :
* PROPOSED BID-WINNING RESULTS OF NATIONAL CENTRALISED
PROCUREMENT
OF PHARMACEUTICALS
* REVENUE OF PROPOSED BID-WINNING PRODUCTS WAS RMB1.12
BILLION
* UNIT PARTICIPATED IN BIDDING FOR NATIONAL CENTRALISED
PROCUREMENT OF PHARMACEUTICALS
* INSULIN PRODUCTS OF CO EXPECTED TO WIN BIDDING IN
CENTRALISED
PROCUREMENT
Further company coverage: 3933.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million